Mosimann F, Cornu P, N'Ziya Z
Department of Surgery, University Hospital (CHUV), Lausanne, Switzerland.
J Hosp Infect. 1997 Sep;37(1):55-64. doi: 10.1016/s0195-6701(97)90073-6.
In a randomized trial of 440 patients undergoing elective colorectal surgery, the prophylactic efficacy and the safety of amoxycillin/clavulanic acid were compared with that of a control regimen of clindamycin and gentamicin. Surgical wound healing was assessed by the ASEPSIS points scale; it was normal in 86% of patients and the scores for both groups were not statistically different (amoxycillin/clavulanic acid: 11.1; clindamycin + gentamicin: 10.9). Intra-abdominal infections were more frequent in the clindamycin + gentamicin arm of the study (Fisher's exact test, P = 0.035). It is concluded that amoxycillin/clavulanic acid is as effective and safe as clindamycin + gentamicin in the prevention of wound infection and may provide better protection against intra-abdominal infections.
在一项针对440例接受择期结直肠手术患者的随机试验中,比较了阿莫西林/克拉维酸与克林霉素和庆大霉素对照方案的预防效果及安全性。通过无菌评分量表评估手术伤口愈合情况;86%的患者伤口愈合正常,两组评分无统计学差异(阿莫西林/克拉维酸:11.1;克林霉素+庆大霉素:10.9)。在该研究中,克林霉素+庆大霉素组发生腹腔内感染更为频繁(Fisher精确检验,P = 0.035)。得出的结论是,阿莫西林/克拉维酸在预防伤口感染方面与克林霉素+庆大霉素同样有效且安全,并且可能对腹腔内感染提供更好的防护。